Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 22 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

Back to table of contents Previous article Next article Association NewsFull AccessAssembly Votes Challenge Threats to Patient CareKen HausmanKen HausmanSearch for more papers by this authorPublished Online:1 Dec 2006https://doi.org/10.1176/pn.41.23.0004Patient care issues had a prominent place on the agenda for the APA Assembly's November meeting in Washington, D.C., and several dealt with prescribing concerns in a health care environment that is not always patient friendly.The representatives passed a paper, for example, whose intent is to“ protect and encourage prescribing” that is both clinically and financially “appropriate.” The proposal addressed the skyrocketing use of drug formularies and pharmacy benefit managers and emphasized that formularies are difficult to use in psychiatry “because of low nosologic specificity, lack of interchangeability of medicines within a class, and a lack of understanding of the mechanism of action of psychotropic medications.” As a result, the Assembly voted to support pharmacy benefit managers that “seek to manage utilization by improving quality, such as by promulgating scientific standards of prescribing through markers of best practices and education.” The vote also included a call to collaborate with the AMA and other specialty organizations on this issue.The Assembly also issued a call to halt the practice of “managed care pharmacists inciting patients to change their medication regimens without disclosing their profit motive.” Assembly representatives were angry about reports of pharmacists affiliated with managed care plans telling patients that they can save money if they switch to a generic or a brand-name drug on the insurer's formulary and urging them to ask their physicians to change their medication.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Hausman, K. (2006). Assembly Votes Challenge Threats to Patient Care. Psychiatric News. https://doi.org/10.1176/pn.41.23.0004

Vancouver

Hausman K. Assembly Votes Challenge Threats to Patient Care. Psychiatric News. 2006. doi:10.1176/pn.41.23.0004.

BibTeX

@article{hausman2006-8f1b2555,
  author  = {Hausman, Ken},
  title   = {{Assembly Votes Challenge Threats to Patient Care}},
  journal = {Psychiatric News},
  year    = {2006},
  doi     = {10.1176/pn.41.23.0004},
  url     = {https://doi.org/10.1176/pn.41.23.0004}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This report describes APA Assembly votes on patient care issues, including a paper intended to protect and encourage clinically and financially appropriate prescribing. It notes concerns that drug formularies are difficult to use in psychiatry because of low nosologic specificity, lack of interchangeability of medicines within a class, and lack of understanding of how psychotropic medications work.

Study details

How this study scored 22/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 1 of 2; Free to read 0 of 2. 21 of the 97 points it could be judged on, which is 22 of 100. Total 22 of 100.21 of the 97 points we could judge = 22 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 21 of the 97 points we could judge it on, which is 22 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Psychiatric News)
Journal's citation record 0 / 4 Psychiatric News: journal h-index 17 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2006 — older than 20 years, still counted
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 22 year(s) since 2006
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Ken Hausman: h-index 5 (OpenAlex, whole career)
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 0 / 2 Behind a paywall — scores zero
Points 21 / 97 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 21 of the 97 points we could judge it on is 22 out of 100.
Total 22 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.

Related studies in Health systems and care delivery

Also in Health systems and care delivery

172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →